A Substance Abuse Treatment Plan: What It Includes

Key Takeaways
- A treatment plan is a working agreement built from a thorough assessment, naming problems, goals, services, responsible parties, and measurable signals, revised as circumstances change rather than filed and forgotten.
- Expect plain-language goals tied to your actual life, a defined level of care, honest evaluation of medication for opioid, alcohol, or nicotine use, and overdose safety spelled out when opioids are involved.
- Measurement-based care and continuing care belong in the plan from day one, with named tools, a review cadence, a confirmed follow-up appointment within 7 or 14 days of discharge 6, and clear triggers for stepping back up.
- Before signing, pin down who wrote the plan, whether goals describe your life, what measures prove progress, who sees what under 42 CFR Part 2 12, and who owns coordination across clinicians, case managers, and recovery associates.
Understanding Your Substance Use Treatment Plan
A substance use treatment plan is a working agreement that documents your current situation, what you want to change, who is responsible for each part, and how everyone will know if it is helping. It is developed from a thorough assessment, revised as circumstances change, and meant to be read, questioned, and shaped by you 1, 2.
If you have just received a multi-page document during a challenging time, take a moment. You are not expected to understand every acronym or clinical term immediately. However, you should recognize if the plan accurately reflects the person it is written about and feel empowered to speak up when it does not.
The following sections will explain what a strong plan includes, the purpose of each component, and important questions to ask before you sign. Consider it a shared script to keep a complex life aligned, rather than a fixed form to simply accept.
What Defines a Substance Use Treatment Plan?
A treatment plan is a written agreement between you, the clinicians involved, and anyone you have authorized to help. It identifies the problems being addressed, the goals you are working toward, the specific services offered to achieve those goals, who is responsible for each element, and how progress will be measured. National guidance emphasizes that no single treatment fits everyone; therefore, a plan should be tailored to the individual, their substance use patterns, and their medical, mental health, and social circumstances 1, 2.
It is not a clinical judgment about you, nor is it a static document that is filed away and forgotten. It is also not a contract that locks you into a fixed path for an extended period, regardless of future developments.
A good plan makes the invisible visible. Instead of assumptions floating between various providers and family members, the plan consolidates everything: your initial situation, agreed-upon actions, and how success will be determined. When circumstances inevitably shift, the plan is revised rather than abandoned.
If the document in front of you reads like a generic template rather than a description of your actual life, this indicates where to begin asking questions.
Developing a Treatment Plan: From Assessment to Agreement
The Foundational Biopsychosocial Assessment
Before any goals are set or levels of care are chosen, a comprehensive understanding of your situation is necessary. This is the purpose of a biopsychosocial assessment. It involves structured conversations to gather information on substance use history, prescribed medications, relevant medical conditions, mental health symptoms, trauma history, and the specifics of your daily life. National guidance highlights that matching treatment settings, services, and interventions to an individual's specific problems and needs is crucial for a plan's effectiveness 2.
A thorough assessment also explores less obvious but equally important details: previous treatment attempts and their outcomes, household dynamics, current employment status, existing prescribers for other conditions, and any custody arrangements, travel schedules, or public roles. These details are not intrusive; they help create a plan for a real person, not just a diagnostic code.
If you are undergoing the assessment, your candor about your desires and boundaries can significantly shape this step. If you are a family member, your observations, offered with your loved one's consent, provide valuable data 1.
The Iterative Process of Treatment Planning
A treatment plan is not a linear progression from intake to discharge; it is an ongoing cycle. Assessment informs goals and interventions, which in turn guide decisions about the level of care and medication. These decisions necessitate specific supports and consent choices. Supports are regularly reviewed using measurable signals, and these reviews inform continuing care. Continuing care then prompts a fresh assessment when circumstances change 2.
SAMHSA's case management guidance identifies key functions that maintain this cycle:
- referral
- coordination of services
- continuing-care planning
- relapse-prevention planning
- discharge planning
All conducted collaboratively with the individual and their authorized support network 3. This means someone ensures communication between providers, tracks referrals, confirms family meetings, and monitors reported changes in sleep, cravings, mood, or work.
Viewing the plan as a loop emphasizes that if any part falters, the entire process can stall. A plan that appears to be a one-time document is likely already outdated. A plan designed as a living agreement anticipates and facilitates revision.
Essential Components of a Treatment Plan
Clear, Plain-Language Goals and Interventions
Goals are the most crucial, yet often misunderstood, part of a plan. Effective goals describe observable outcomes: fewer drinking days per week, consistent attendance at therapy, a stable sleep schedule, a return to a specific work routine, or renewed contact with a child. Vague goals like "improve wellness" or "reduce substance use" allow for varied interpretations of success, often leading to a lack of measurement 2.
Each goal should be supported by a list of interventions—the specific services designed to help you achieve it. This might include individual therapy with a licensed clinician on a defined schedule, medication evaluation, group work, family sessions, or coordination calls between providers. For each intervention, the plan should name the responsible party, frequency, and the signal indicating its effectiveness 2.
Read the goals aloud. If they accurately describe your life, the plan is well-aligned. If they could apply to anyone, request a rewrite for greater specificity.
Level of Care, Setting, and Medication Considerations
The level of care indicates the intensity and structure of your treatment, ranging from medically managed withdrawal and residential care to partial hospitalization, intensive outpatient, and standard outpatient therapy. Your plan should specify your starting level, justify its appropriateness based on the assessment, and outline criteria for stepping down or stepping up 1, 2.
Setting, while related, is a distinct decision. Options include residential, outpatient, in-home support with a recovery associate, or travel-based support. For individuals whose work, custody, or health circumstances make traditional residential care impractical, the setting discussion is critical for ensuring the plan reflects real-life needs.
Medication should be explicitly addressed. For opioid use disorder, SAMHSA and CDC guidance endorse buprenorphine, methadone, and naltrexone, each used in conjunction with behavioral and support services 4, 5. Medications also play a role in treating alcohol and nicotine use disorders 1. If the plan involves opioids, alcohol, or nicotine, it should clearly state whether medication was evaluated, what was recommended, who is prescribing and monitoring it, and how that prescriber communicates with the rest of the team.
Overdose Safety and Household Education
If opioids are involved, your plan should prioritize overdose safety. CDC clinical guidance recommends offering naloxone and education on its proper use to patients and household members 5. This means the plan should specify who in the home has naloxone, its location, and who has been trained to use it.
This is important even when progress is being made, as risk is highest after a period of reduced tolerance, such as after medically managed withdrawal or residential care. Household education also includes knowing when to call 911 and having the 988 Suicide & Crisis Lifeline readily available for mental health emergencies. If your plan treats overdose prevention as a formality rather than essential preparation, request a revision.
Measuring Progress: The Role of Measurement-Based Care
Measurement-based care involves using validated, repeated assessments to track symptoms, substance use, functioning, safety, and treatment engagement, allowing these readings to guide subsequent plan adjustments. A 2024 review describes it as a promising precision strategy for substance use disorder treatment, though its implementation remains inconsistent across programs 8. In your plan, this means objective data and signals are regularly reviewed, rather than relying solely on subjective impressions.
In practice, this might involve:
- a brief standardized questionnaire about cravings, mood, or sleep at each visit
- a log of substance use days
- a functioning measure tracking work, relationships, and daily routines
- a safety check for overdose risk or suicidal thoughts
When any of these indicators move negatively, the plan is revisited. When they improve, the plan can be adjusted with evidence, not guesswork.
Why is this important? Documented processes do not automatically guarantee reported outcomes. A 2025 systematic review of adult mental health services found that only 12% of included studies reported treatment information, and none reported substance use disorder outcomes 9. This highlights a research gap and serves as a warning: services can appear thorough on paper while leaving the question of actual improvement unanswered.
You can directly inquire about this. Ask which validated tools are used, how often results will be reviewed with you, and what specific signals will prompt a change in the plan. If no one can name the measures, the plan is likely operating on impressions.
Integrating Continuing Care from the Start
The transition point is often the weakest link in many treatment plans. After medically managed withdrawal or residential care, discharge paperwork is completed, and the next appointment is vaguely scheduled for "within a few weeks." This gap is where plans often fail. A plan that treats continuing care as an afterthought risks leaving the individual with the least support during their most vulnerable period.
The continuing-care section should be developed while the individual is still in a higher level of care, not on the day of discharge. SAMHSA's case management guidance emphasizes that continuing-care planning, relapse-prevention planning, and discharge planning should occur collaboratively with the individual and their authorized support network 3. This means the next therapist is identified, the first outpatient appointment is scheduled, the prescriber knows the discharge date, the pharmacy has the current prescription, and any in-home or transitional support providers are aware of their start date.
CMS provides a useful benchmark: follow-up substance use treatment within 7 or 14 days after withdrawal management or inpatient/residential discharge 6. You can ask the discharging program which timeframe your plan aims to meet and who is responsible for confirming the appointment occurred. Without clear ownership of this confirmation, the benchmark is merely aspirational.
Continuing care also involves defining triggers for stepping back up in care. This could include a missed week of appointments, a return to substance use, sleep disruption, or a travel schedule that removes structure. Deciding in advance how to respond to these signals ensures the plan adapts proactively rather than requiring a complete restart.
Consent, Privacy, and Information Sharing
Privacy decisions should be an integral part of the treatment plan, not relegated to a separate, easily forgotten form. Federal protections for substance use records under 42 CFR Part 2 generally restrict disclosure that would identify someone as having a substance use disorder, with limited exceptions for medical emergencies and court orders 12. A 2024 final rule aligned parts of Part 2 with HIPAA, introducing a single-consent model that can cover future uses and disclosures for treatment, payment, and healthcare operations 11. This means one carefully crafted consent can authorize ongoing coordination among your team, eliminating the need for new signatures for every communication.
Your plan should explicitly name who may receive information and what type of information they can access. This includes the psychiatrist, therapist, primary care physician, in-home recovery associate, spouse or adult child, and any attorneys or trustees involved in estate, custody, or employment matters. For each person, specify the scope of information they receive: clinical details, scheduling only, safety concerns only, or full coordination access. Vague consent can lead to either unintended oversharing or hinder necessary communication.
Two practical questions to ask before signing: First, what happens in an emergency where you cannot provide consent? Part 2 permits limited disclosure for emergency medical care, and your plan should outline who is contacted and in what order 12. Second, who maintains the signed consents, and how can they be revoked? You have the right to withdraw or narrow consent at any time, and the plan should clearly detail this process.
If attorneys, wealth managers, or employer counsel are involved, decide upfront what information they receive. A plan that treats this as mere paperwork can inadvertently lead to the kind of oversharing that high-profile families often seek to avoid.
Defining Roles: Clinicians, Case Managers, and Recovery Associates
A plan listing multiple providers without clear roles is prone to failure. Clearly defining responsibilities ensures everyone knows who makes which call.
Licensed clinicians perform clinical work. Psychiatrists and addiction medicine specialists evaluate and prescribe medication, including FDA-approved medications for opioid use disorder 4, 5. Therapists (LMFTs, LMHCs, psychologists, licensed social workers) diagnose, provide therapy, and manage clinical risk. Nurses handle medical monitoring. These professionals hold prescribing authority, clinical decision-making, and the responsibility for diagnoses that drive the plan.
Case management focuses on coordination. SAMHSA's guidance describes this role as facilitating referrals, connecting services, and planning for continuing care, relapse prevention, and discharge, all in collaboration with the individual and their authorized network 3. A case manager does not prescribe or provide therapy; instead, they ensure that all involved parties—psychiatrist, therapist, program, pharmacy, and family—are working cohesively and that the written plan aligns with real-time events.
Recovery associates and wellness associates provide nonclinical support. They offer presence, structure, and continuity between appointments, whether at home, during travel, or through transitions from residential care. A recent peer-reviewed review indicates that peer recovery support and coaching can improve treatment engagement and retention, with substance-use outcome evidence still emerging 10. Essentially, nonclinical support helps individuals stay connected to their clinical plan; it does not replace it.
Your plan should name each person in these roles, their contact information, and the escalation path for when circumstances change.
Key Questions to Ask Before Signing Your Treatment Plan
Before signing any document, review your treatment plan carefully. These are critical questions to ask aloud and address before finalizing the document:
- Who wrote this plan, and who was consulted? A plan based solely on a single intake interview is a draft. Ask which clinicians contributed and if any authorized individuals were consulted 2.
- Do the goals accurately describe my life? If a goal is generic, request specific objectives tied to your work, family, and daily routines 2.
- What measures will track progress, and how often will they be reviewed? Ask for the names of the tools and the review schedule. Impressions are not sufficient for measurement 8.
- If medication is relevant, was it evaluated and by whom? For opioid, alcohol, or nicotine use, a plan that overlooks medication evaluation is incomplete 1, 4.
- What are the specific details for the first two weeks post-discharge? Ask who is responsible for the follow-up appointment and confirming its completion 6.
- Who sees what information, and how can I modify this later? Confirm that consent decisions are documented and can be revoked or narrowed 11.
If any question receives a vague answer, that is the section of the plan to address first.
Guidance for Coordinating Care Across Providers, Family, and Advisors
This section is for family members, spouses, or professionals who are coordinating care, especially when the individual in treatment is focused on their immediate needs. If this describes your role, the treatment plan is your primary tool.
Begin by designating one person, typically a case manager, to maintain the current version of the document. This ensures consistency, as this individual updates the plan when changes occur and distributes the revised version to all authorized parties. SAMHSA's case management guidance highlights this coordination role as the connective tissue for referrals, service delivery, continuing care, and discharge planning, all done in collaboration with the individual and their authorized network 3.
Next, establish clear communication protocols. Define who contacts whom when medication changes, an appointment is missed, travel is planned, or a family event occurs. Document the escalation path within the plan itself to avoid guesswork during urgent situations. Keep attorneys, trustees, and employer counsel on a more restricted information pathway than the clinical team, unless there is a specific reason to broaden access, and ensure this choice is documented in the consent record for long-term validity 11.
Finally, schedule regular, brief coordination calls, even short ones. Plans can become outdated between appointments. A fifteen-minute check-in among authorized individuals can address issues before they escalate into crises.
A Confidential Conversation About Your Situation
If you are navigating a treatment plan you don't fully understand, or coordinating care across multiple providers, family members, and advisors, you don't have to do it alone. Next Level Wellness & Behavioral Health is a concierge behavioral health firm offering case management, recovery and wellness associates, interventions, and transitional care. Based in Boca Raton, we work with individuals and families nationally and internationally. Founded by Amanda Marino, our approach centers on coordination that keeps providers, family, and daily life aligned, with the discretion high-profile situations require. If you would like a confidential conversation about your situation, or if you are a referring professional with a client who needs private support, we are here. Creating Lasting Change starts with one call.
Frequently Asked Questions
Who writes a substance use treatment plan, and do I get a say in it?
A licensed clinician typically drafts the plan after a biopsychosocial assessment, but it should be developed collaboratively with you. National guidance emphasizes that matching services to an individual's specific problems and needs is essential, meaning your input on goals, setting, and family involvement should be included 2.
How often should a treatment plan be reviewed or updated?
What's the difference between a clinician, a case manager, and a recovery associate on my plan?
Clinicians diagnose, prescribe, and provide therapy. Case managers coordinate services, including referrals, service connections, continuing-care planning, and discharge planning, in collaboration with you and your authorized network 3. Recovery associates offer nonclinical support, providing presence and continuity between appointments; evidence suggests they improve engagement and retention, with substance-use outcome evidence still preliminary 10.
Can my family see the plan, and what does 42 CFR Part 2 mean for us?
Family access requires your written consent. 42 CFR Part 2 generally restricts disclosure that identifies someone as having a substance use disorder, with narrow exceptions for medical emergencies and court orders 12. A 2024 final rule introduced a single-consent model that can authorize ongoing coordination for treatment, payment, and healthcare operations 11.
What should continuing care look like after a higher level of care ends?
Continuing care should be planned before discharge, not after. This includes identifying a therapist, confirming the first outpatient appointment, ensuring communication with the prescriber, and assigning someone to confirm the follow-up appointment occurred. CMS suggests a benchmark of substance use treatment within 7 or 14 days after withdrawal management or inpatient/residential discharge 6.
What can I push back on if the plan I was handed doesn't fit my life?
You can challenge vague goals, the absence of medication evaluation for opioid, alcohol, or nicotine use, unnamed measurement tools, undefined review schedules, and consent language that is broader than you prefer 1, 8. A plan is a working agreement; request specific rewrites tailored to your work, family, and daily routines before signing.
References
- Treatment and Recovery. https://nida.nih.gov/publications/science-addiction/treatment-recovery
- Principles of Drug Addiction Treatment. https://nida.nih.gov/sites/default/files/podat_1.pdf
- TIP 27: Comprehensive Case Management for Substance Abuse Treatment. https://library.samhsa.gov/sites/default/files/sma15-4215.pdf
- Medications for Opioid Use Disorder. https://library.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-02-01-006.pdf
- Opioid Use Disorder: Treating. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-treating.html
- Reducing Substance Use Disorders: Quality Measures. https://www.medicaid.gov/resources-for-states/innovation-accelerator-program/functional-areas/quality-measurement/reducing-substance-use-disorders-quality-measures
- 2025 Core Set of Behavioral Health Measures for Medicaid and CHIP. https://www.medicaid.gov/medicaid/quality-of-care/downloads/2025-bh-core-set.pdf
- Using Measurement-Based Care as a Precision Medicine Strategy for Substance Use Disorders. https://pubmed.ncbi.nlm.nih.gov/38489141/
- Comprehensive care processes for substance use disorders in adult mental health services: A systematic review. https://pubmed.ncbi.nlm.nih.gov/39817501/
- Peer Recovery Support Services and Recovery Coaching for Substance Use Disorder. https://pubmed.ncbi.nlm.nih.gov/41551498/
- Fact Sheet 42 CFR Part 2 Final Rule. https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html
- Understanding Confidentiality of Substance Use Disorder (SUD) Patient Records or "Part 2". https://www.hhs.gov/hipaa/part-2/index.html
Insight Beyond Treatment
At Next Level Wellness & Behavioral Health, we believe meaningful change starts with perspective, not just protocols.
That philosophy is directly led by Amanda Marino, whose voice in behavioral health extends beyond clinical settings into leadership, culture, and personal growth.
Through keynote speaking and live events, Amanda explores the deeper themes that show up in recovery, family systems, and life transitions: authenticity, resilience, accountability, and the courage to change. Her work invites audiences to move past labels and into honest conversations that create lasting impact.
A Voice Shaping the Conversation
The topics explored here—change, self-awareness, recovery, and growth—are the same themes Amanda Marino brings to audiences nationwide through speaking engagements and live events.
Known for her appearances on A&E’s Intervention and Digital Addiction, Amanda speaks to organizations, communities, and leadership teams about navigating adversity, embracing vulnerability, and building lives rooted in purpose. Her message resonates far beyond treatment, offering insight that applies to families, professionals, and anyone standing at a crossroads.


